{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:24:30Z","timestamp":1787239470929,"version":"build-2736575974"},"reference-count":67,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Thyrotropin receptor antibodies (TRAb) are specific for Graves\u2019 disease (GD) and\n                    play a crucial role in the pathogenesis of GD. TRAb assays have recently been\n                    greatly improved. This review discusses the clinical application of TRAb in the\n                    differential diagnosis of hyperthyroidism, the prognosis of GD, GD in gestation\n                    and pediatrics, and GD related ophthalmopathy (GO). In addition to the classical\n                    competition and bioassays, a new bridging assay has emerged for TRAb assays.\n                    TRAb is the main pathogenic mechanism of hyperthyroidism in GD. Treated GD still\n                    has a high rate of recurrence and even a short-term surge of TRAb, leading to\n                    rapid deterioration of GO. Fetal goiter may be associated with elevated maternal\n                    TRAb during pregnancy, overtreatment may lead to fetal hypothyroidism. Pediatric\n                    patients with GD have high TRAb, poor remission from treatment, and\n                    insignificant manifestations of GO. TRAb is significantly correlated with GO\n                    activity and severity. Currently, TRAb assay has high specificity and\n                    sensitivity and can be used directly to identify the cause of hyperthyroidism.\n                    TRAb can be used to predict recurrence of drug treated GD or progression of GO\n                    after RAI therapy. TRAb should be measured regularly for GD in gestation to\n                    guide anti-thyroid medication to avoid thyrotoxicosis or hypothyroidism in the\n                    fetus. Monitoring TRAb in pediatric GD may help control the progression of GO.\n                    TRAb assay is an important guide for the treatment of GO.<\/jats:p>","DOI":"10.1055\/a-2498-8050","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T19:17:52Z","timestamp":1733771872000},"page":"79-87","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Application of Thyrotropin Receptor\n                    Antibodies"],"prefix":"10.1055","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5425-9998","authenticated-orcid":false,"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Lanzhou\n                    University Second Clinical Medical School, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Lanzhou\n                    University Second Clinical Medical School, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-8587(23)00005-0","article-title":"Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications,\n                    and prognosis","volume":"11","author":"W M Wiersinga","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves\u2019 disease","volume":"6","author":"T F Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"T J Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/thy.2012.0500","article-title":"Graves\u2019 disease and toxic nodular goiter are both associated with increased\n                    mortality but differ with respect to the cause of death: a Danish\n                    populationbased register study","volume":"23","author":"F Brandt","year":"2013","journal-title":"Thyroid"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-16-0576","article-title":"Acute cardiovascular events and allcause mortality in patients with\n                    hyperthyroidism: a populationbased cohort study","volume":"176","author":"O M Dekkers","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/er.2018-00163","article-title":"Thyroid dysfunction and diabetes mellitus: two closely associated disorders","volume":"40","author":"B Biondi","year":"2019","journal-title":"Endocr Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1158\/1055-9965.EPI-18-0877","article-title":"A linkage between thyroid and breast cancer: a common etiology?","volume":"28","author":"E L Bolf","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1210\/jc.2017-00166","article-title":"Excess mortality in treated and untreated hyperthyroidism is related to\n                    cumulative periods of low serum TSH","volume":"102","author":"M Lillevang-Johansen","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","first-page":"11","article-title":"Abnormal responses in the assay of thyrotropins","volume":"34","author":"D D Adams","year":"1956","journal-title":"Proc Univ Otago Med School"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/08830189909043021","article-title":"T-cell receptors and autoimmune thyroid disease--signposts for T-cell-antigen\n                    driven diseases","volume":"18","author":"A Martin","year":"1999","journal-title":"Int Rev Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI200317069","article-title":"The thyrotropin receptor autoantigen in Graves disease is the culprit as well as\n                    the victim","volume":"111","author":"C R Chen","year":"2003","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/thy.2007.0034","article-title":"Crystal structure of the TSH receptor in complex with a thyroid-stimulating\n                    autoantibody","volume":"17","author":"J Sanders","year":"2007","journal-title":"Thyroid"},{"key":"ref13","first-page":"81","article-title":"Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR\n                    autoantibody","volume":"46","author":"P Sanders","year":"2011","journal-title":"J Mol Endocrinol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/en.2008-0878","article-title":"Characterization of thyrotropin receptor antibody-induced signaling\n                    cascades","volume":"150","author":"S A Morshed","year":"2009","journal-title":"Endocrinology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/thy.2012.0374","article-title":"Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies:\n                    potential mechanisms involved in the pendulum swinging from hypothyroidism to\n                    hyperthyroidism or vice versa","volume":"23","author":"S M McLachlan","year":"2013","journal-title":"Thyroid"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0035-1559633","article-title":"Graves\u2019 disease mechanisms: the role of stimulating, blocking, and cleavage\n                    region TSH receptor antibodies","volume":"47","author":"S A Morshed","year":"2015","journal-title":"Horm Metab Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1210\/en.2010-0424","article-title":"Neutral antibodies to the TSH receptor are present in Graves\u2019 disease and\n                    regulate selective signaling cascades","volume":"151","author":"S A Morshed","year":"2010","journal-title":"Endocrinology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri750","article-title":"Autoimmune thyroid disease: new models of cell death in autoimmunity","volume":"2","author":"G Stassi","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.semnuclmed.2023.11.002","article-title":"Autoimmune thyroid diseases","volume":"54","author":"P P Ov\u010dari\u010dek","year":"2024","journal-title":"Semin Nucl Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.autrev.2012.07.003","article-title":"TSH receptor autoantibody immunoassay in patients with Graves\u2019 disease:\n                    improvement of diagnostic accuracy over different generations of methods.\n                    Systematic review and meta-analysis","volume":"12","author":"R Tozzoli","year":"2012","journal-title":"Autoimmun Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1210\/jc.2012-4309","article-title":"Clinical utility of TSH receptor antibodies","volume":"98","author":"G Barbesino","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/1050725042451248","article-title":"A new assay for thyrotropin receptor autoantibodies","volume":"14","author":"B R Smith","year":"2004","journal-title":"Thyroid"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2265.2008.03512.x","article-title":"Clinical value of the first automated TSH receptor autoantibody assay for the\n                    diagnosis of Graves\u2019 disease (GD): an international multicentre trial","volume":"71","author":"M Schott","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1210\/jcem-52-6-1204","article-title":"Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid\n                    cells","volume":"52","author":"W E Hinds","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of\n                    activity and severity of Graves\u2019 orbitopathy","volume":"95","author":"S D Lytton","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"119700","DOI":"10.1016\/j.cca.2024.119700","article-title":"Thyroid stimulating receptor autoantibodies","volume":"559","author":"Y M Gao","year":"2024","journal-title":"Clin Chim Acta"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1055\/s-0035-1554662","article-title":"Bridge technology with TSH receptor chimera for sensitive direct dDetection of\n                    TSH receptor antibodies causing Graves\u2019 disease: analytical and clinical\n                    evaluation","volume":"47","author":"C U Frank","year":"2015","journal-title":"Horm Metab Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2741\/4708","article-title":"Graves\u2019 disease in clinical perspective","volume":"24","author":"M Ehlers","year":"2019","journal-title":"Front Biosci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00365513.2019.1658216","article-title":"Analytical and clinical performance of newly developed immunoassay for detecting\n                    thyroid-stimulating immunoglobulin, the Immulite TSI assay","volume":"79","author":"J J Kim","year":"2019","journal-title":"Scand J Clin Lab Invest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/a-0914-0535","article-title":"Comparison of a bridge immunoassay with two bioassays for thyrotropin receptor\n                    antibody detection and differentiation","volume":"51","author":"S Allelein","year":"2019","journal-title":"Horm Metab Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/thy.2011.2106.ed3","article-title":"The American thyroid association\/American association of clinical\n                    endocrinologists guidelines for hyperthyroidism and other causes of\n                    thyrotoxicosis: a European perspective","volume":"21","author":"G J Kahaly","year":"2011","journal-title":"Thyroid"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American thyroid association guidelines for diagnosis and management of\n                    hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"D S Ross","year":"2016","journal-title":"Thyroid"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.autrev.2010.05.021","article-title":"Clinical review about TRAb assay\u2019s history","volume":"9","author":"K Z\u00f6phel","year":"2010","journal-title":"Autoimmun Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2265.2009.03696.x","article-title":"Natural history of subclinical hyperthyroidism in elderly patients with TSH\n                    between 0.1 and 0.4 mIU\/l: a prospective study","volume":"72","author":"P W Rosario","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid\n                    drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"P Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0035-1555759","article-title":"Outcome prediction of treatment of Graves\u2019 hyperthyroidism with antithyroid\n                    drugs","volume":"47","author":"E Piantanida","year":"2015","journal-title":"Horm Metab Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/jcp-2022-208290","article-title":"Thyroid autoantibodies","volume":"76","author":"S K Dwivedi","year":"2023","journal-title":"J Clin Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IOP.0000000000001052","article-title":"Thyrotropin receptor antibodies \u2013 an overview","volume":"34","author":"A Kotwal","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(23)02016-0","article-title":"Hyperthyroidism","volume":"403","author":"L Chaker","year":"2024","journal-title":"Lancet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1210\/clinem\/dgaa646","article-title":"Management of Graves thyroidal and extrathyroidal disease: an update","volume":"105","author":"G J Kahaly","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1210\/clinem\/dgaa945","article-title":"Testing, monitoring, and treatment of thyroid dysfunction in pregnancy","volume":"106","author":"S Y Lee","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2213-8587(13)70086-X","article-title":"Hyperthyroidism in pregnancy","volume":"1","author":"D S Cooper","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41574-021-00604-z","article-title":"Assessment and treatment of thyroid disorders in pregnancy and the postpartum\n                    period","volume":"18","author":"S Y Lee","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a\n                    population-based cohort study","volume":"78","author":"M T Wang","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1089\/thy.2019.0045","article-title":"Analysis of antithyroid drug-induced severe liver injury in 18,558 newly\n                    diagnosed patients with Graves\u2019 disease in Japan","volume":"29","author":"N Suzuki","year":"2019","journal-title":"Thyroid"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish\n                    nationwide study","volume":"98","author":"S L Andersen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MED.0000000000000492","article-title":"Graves\u2019 hyperthyroidism in pregnancy","volume":"26","author":"C T Nguyen","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ecl.2019.05.002","article-title":"Hyperthyroidism and pregnancy","volume":"48","author":"K Kobaly","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American thyroid association for the diagnosis and\n                    management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"E K Alexander","year":"2017","journal-title":"Thyroid"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamaoto.2021.2715","article-title":"Management of pediatric Graves disease: a review","volume":"147","author":"L Quintanilla-Dieck","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e20151878","DOI":"10.1542\/peds.2015-1878","article-title":"Management of neonates born to mothers with Graves\u2019 Disease","volume":"137","author":"D C van der Kaay","year":"2016","journal-title":"Pediatrics"},{"key":"ref52","first-page":"bcr0220125939","article-title":"Neonatal thyrotoxicosis presenting as persistent pulmonary hypertension","author":"R Obeid","year":"2012","journal-title":"BMJ Case Rep"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e1048","DOI":"10.1542\/peds.2012-3000","article-title":"Thyroid \u201cvise\u201d in an infant with neonatal Graves\u2019 disease","volume":"132","author":"M O Regelmann","year":"2013","journal-title":"Pediatrics"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MED.0000000000000521","article-title":"Update on pediatric hyperthyroidism","volume":"27","author":"P B Kaplowitz","year":"2020","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1210\/js.2017-00189","article-title":"Study of the factors leading to fetal and neonatal dysthyroidism in children of\n                    patients with Graves Disease","volume":"1","author":"M Banig\u00e9","year":"2017","journal-title":"J Endocr Soc"},{"key":"ref56","first-page":"66","article-title":"Graves\u2019 disease in childhood: new epidemiological, pathophysiological and\n                    therapeutic insights","volume":"68","author":"F De Luca","year":"2016","journal-title":"Minerva Pediatr"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-18-0039","article-title":"Predictive score for the development or progression of Graves\u2019 orbitopathy in\n                    patients with newly diagnosed Graves\u2019 hyperthyroidism","volume":"178","author":"W Wiersinga","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves\n                    orbitopathy","volume":"16","author":"P N Taylor","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaophthalmol.2018.0806","article-title":"Association of T and B cells infiltrating orbital tissues with clinical features\n                    of Graves orbitopathy","volume":"136","author":"D G Rotondo","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"ref60","first-page":"412158","article-title":"Markers of inflammation and fibrosis in the orbital fat\/connective tissue of\n                    patients with Graves\u2019 orbitopathy: clinical implications","author":"P Pawlowski","year":"2014","journal-title":"Mediators Inflamm"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00417-021-05456-x","article-title":"The risk factors for Graves\u2019 ophthalmopathy","volume":"260","author":"J Cao","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"E1183","DOI":"10.1210\/jc.2013-4182","article-title":"Possible targets for nonimmunosuppressive therapy of Graves\u2019 orbitopathy","volume":"99","author":"L Zhang","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1210\/jc.2016-1315","article-title":"TSH\/IGF-1 receptor cross talk in Graves\u2019 ophthalmopathy pathogenesis","volume":"101","author":"C C Krieger","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jc.2014-3566","article-title":"Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of\n                    hyaluronan secretion by Graves\u2019 disease immunoglobins","volume":"100","author":"C C Krieger","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/joim.13524","article-title":"Current concepts regarding Graves\u2019 orbitopathy","volume":"292","author":"L Bartalena","year":"2022","journal-title":"J Intern Med"},{"key":"ref66","first-page":"1597","article-title":"Blocking the thyrotropin receptor with K1-70 in a patient with follicular\n                    thyroid cancer, Graves\u2019 disease, and Graves\u2019 ophthalmopathy","volume":"31","author":"M Ryder","year":"2021","journal-title":"Thyroid"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/cen.14681","article-title":"TSH receptor specific monoclonal autoantibody K1-70TM targeting of\n                    the TSH receptor in subjects with Graves' disease and Graves\u2019 orbitopathy \u2013\n                    results from a phase I clinical trial","volume":"96","author":"J Furmaniak","year":"2022","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Hormone and Metabolic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2498-8050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T18:30:42Z","timestamp":1739212242000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2498-8050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":67,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,2,10]]},"published-print":{"date-parts":[[2025,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2498-8050","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12,9]]},"published":{"date-parts":[[2024,12,9]]}}}